Behind every healthier future is a healthcare professional making a difference.
TIME and Johnson & Johnson are proud to launch the search for the first-ever ... Show more
Site Maintenance
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Similar to This
Previous
Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ: Johnson & Johnson signals a DePuy Synthes orthopedics spinout, not a sale—what it ...
seekingalpha.com/news/4652599-johnson-johnson-leaning-toward-spinning-out-hips-and-knees-business---wsj
Johnson & Johnson Clinical Trials Show Progress Across Key Therapies - Johnson & Johnson (NYSE:JNJ)
benzinga.com/news/health-care/26/09/61998704/johnson-johnson-clinical-trials-show-progress-across-key-therapies
J&J enters US robotic surgery market after device gets marketing authorization: Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had ...
finance.yahoo.com/healthcare/articles/j-j-enters-us-robotic-112150242.html
Are MAGA and MAHA Heading for Divorce?: Robert F. Kennedy Jr. promised ambitious plans to make Americans healthier. But insiders say as soon as he was named ...
rollingstone.com/politics/politics-features/maha-maga-alliance-fracture-robert-kennedy-jr-1235582070/
J&J drops key multiple myeloma cancer trial results : Johnson & Johnson (JNJ) spent 2025 proving it could lose a multibillion-dollar drug and still grow.
charlotteobserver.com/news/business/article316148885.html
Knappschaft Clinics in Buer rely on a new procedure: "More targeted treatment": The team around Dr. Patrick Müller (second from right) and Dr. Igor Janda ...
waz.de/lokales/gelsenkirchen/article412108633/knappschaft-kliniken-in-buer-setzen-auf-neues-verfahren-gezielter-behandeln.html
Johnson & Johnson: The Return Of The Dividend King: Consensus projects Johnson & Johnson's EPS CAGR of 8.9% (2026–2030), with forward P/E compressing from 20 ...
seekingalpha.com/article/4887302-johnson-and-johnson-the-return-of-the-dividend-king
Paid articlePaywall SA Asks: What are the best dividend stocks right now?: What are the best dividend stocks right now for investors? Seeking Alpha analysts weigh in. Read more here ...
seekingalpha.com/news/4504516-sa-asks-what-are-the-best-dividend-stocks-right-now
Paid articlePaywall
J&J to spin off orthopedics business, sees 2026 sales growth of over 5%: Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a ...
bnnbloomberg.ca/business/2025/10/14/jj-to-spin-off-orthopedics-business-sees-2026-sales-growth-of-over-5/
Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff
marketwatch.com/story/johnson-johnsons-stock-heads-for-a-record-after-a-profit-beat-and-plans-for-another-spinoff-af403f00
Paid articlePaywall
Johnson & Johnson in talks to acquire Protagonist Therapeutics, source says: Johnson & Johnson is in discussions to buy Protagonist Therapeutics ...
reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-talks-acquire-protagonist-therapeutics-wsj-reports-2025-10-10/
‘The Johnson & Johnson Files’ review: The Indian Express journalist Kaunain Sheriff M exposes the global giant’s dark legacy in India
indianexpress.com/article/books-and-literature/the-johnson-johnson-files-review-the-indian-express-journalist-kaunain-sheriff-m-exposes-the-global-giants-dark-legacy-in-india-10301194/
Paid articlePaywall
Yeti Might Be Out of the Woods After a Drinkware Spill: Yeti shares soared after our 2019 bullish article, then backtracked. New products can keep the company on ...
barrons.com/articles/yeti-stock-sales-slump-johnson-and-johnson-healthcare-eb198d2f
Paid articlePaywall Johnson & Johnson’s stock surges as tariff-cost estimate is slashed and profit outlook raised
marketwatch.com/story/johnson-johnsons-stock-rallies-after-earnings-beat-and-outlook-raised-amid-strength-in-heart-and-cancer-treatments-5d66f50b
Paid articlePaywall
How Johnson & Johnson Misled America: The mega institution has acted brazenly and sometimes illegally, pursuing profit over care.
theatlantic.com/books/archive/2025/05/no-more-tears-johnson-johnson-alzheimers-health-care-book-review/682856/
J&J's Biosense Webster ordered to pay $147M in antitrust lawsuit: A California jury found Biosense Webster guilty of antitrust violations for denying support to ...
modernhealthcare.com/legal/johnson-johnson-biosense-webster-antitrust
Paid articlePaywall
Trump to sign order to cut some U.S. drug prices to match those abroad
cnbc.com/2025/05/12/trump-drug-pricing-order-most-favored-nation.html
Business Review Nov 14 24
BR Interview | Johnson & Johnson driving healthcare innovation in Romania: BR Exclusive - Having been present on the local market for more than 30 years now ...
business-review.eu/br-exclusive/br-interview-johnson-johnson-driving-healthcare-innovation-in-romania-274668
Key FactsJohnson & Johnson: Pioneering Healthcare Innovation in Romania
Nov 14, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: business-review.eu
Summary created with AI assistance · Source: business-review.eu
- Johnson & Johnson has been dedicated to Romanian society for over 30 years, focusing on education and health.
- The company offers scholarships to medical students and promotes digital health innovations through university partnerships.
- The Hackathon4Health initiative allows young innovators to develop their ideas with funding and mentorship from Johnson & Johnson and the university.
- Future goals include combating cancer with numerous new drug approvals planned by 2030.
Next